Rational design of original fused-cycle selective inhibitors of tryptophan 2,3-dioxygenase
Tryptophan 2,3-dioxygenase (TDO2) is a heme-containing enzyme constitutively expressed at high concentrations in the liver and responsible for l-tryptophan (l-Trp) homeostasis. Expression of TDO2 in cancer cells results in the inhibition of immune-mediated tumor rejection due to an enhancement of l-...
主要な著者: | Kozlova, A, Thabault, L, Liberelle, M, Klaessens, S, Prévost, JRC, Mathieu, C, Pilotte, L, Stroobant, V, Van den Eynde, B, Frédérick, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
American Chemical Society
2021
|
類似資料
-
Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase
著者:: Kozlova, A, 等
出版事項: (2021) -
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
著者:: Klaessens, S, 等
出版事項: (2021) -
Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937
著者:: Hoffmann, D, 等
出版事項: (2019) -
Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors
著者:: Schramme, F, 等
出版事項: (2019) -
Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
著者:: Delia Hoffmann, 等
出版事項: (2020-12-01)